Comparative Humoral Immune Responses Induced by Live-Attenuated and Inactivated Porcine Epidemic Diarrhea Vaccines in Replacement Gilts
Vaccines · 28.02.2026 · 14 (3) · 231
DOI: 10.3390/vaccines14030231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 28.02.2026. Verfasst von Prapassorn Boonsoongnern und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Veterinary Medicine, Kasetsart University.
Abstract (Originalsprache)
Background/Objectives: Porcine epidemic diarrhea (PED) is a highly contagious enteric disease caused by porcine epidemic diarrhea virus (PEDV) and is associated with severe clinical signs and high mortality in neonatal piglets. Vaccination is an important strategy for PED control through the induction of humoral immunity. This study aimed to compare immune responses induced by inactivated and live-attenuated PEDV vaccines and to evaluate a heterologous prime-boost vaccination strategy in PEDV-naïve replacement gilts.
Methods
Twenty-four PEDV-naïve replacement gilts were randomly assigned to four groups: unvaccinated control, inactivated vaccine administered twice (K/K), live-attenuated vaccine administered twice (L/L), and live-attenuated priming followed by an inactivated booster (L/K). Pigs received two intramuscular vaccinations at 16 weeks of age and two weeks later. Serum samples collected up to 42 days post-vaccination were analyzed for PEDV-specific IgG and IgA antibodies by ELISA, and serum-neutralizing antibody titers were determined using a serum neutralization test.
Results
The L/K regimen induced the highest PEDV-specific IgG responses, with peak levels at day 28 post-vaccination that were significantly higher than those in the K/K and control groups. Serum-neutralizing antibody titers were significantly higher in the L/K and L/L groups than in the K/K and control groups. Serum IgA responses were low and transient across all vaccination groups.
Conclusions
A heterologous prime-boost vaccination strategy using a live-attenuated PEDV vaccine followed by an inactivated booster induces strong systemic humoral immune responses in replacement gilts and represents a promising approach for PEDV vaccination programs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand.
- Department of Farm Resources and Production Medicine, Faculty of Veterinary Medicine, Kasetsart University, Nakhon Pathom 73140, Thailand.
- Akkharatchakumari Veterinary College, Walailak University, Nakhon Si Thammarat 80160, Thailand.
ORCID-Profile: Narut Thanantong
Förderung
- Faculty of Veterinary Medicine, Kasetsart University
Zitieren
APA
Boonsoongnern, P., Boodde, O., Chumsing, W., Jirawattanapong, P., Sukmak, M., Woonwong, Y., Thanantong, N., Wajjwalku, W., & Boonsoongnern, A. (2026). Comparative Humoral Immune Responses Induced by Live-Attenuated and Inactivated Porcine Epidemic Diarrhea Vaccines in Replacement Gilts. Vaccines, 14(3), 231. https://doi.org/10.3390/vaccines14030231
Vancouver
Boonsoongnern P, Boodde O, Chumsing W, Jirawattanapong P, Sukmak M, Woonwong Y, et al. Comparative Humoral Immune Responses Induced by Live-Attenuated and Inactivated Porcine Epidemic Diarrhea Vaccines in Replacement Gilts. Vaccines. 2026;14(3):231. doi:10.3390/vaccines14030231
BibTeX
@article{Boonsoongnern2026,
author = {Boonsoongnern, Prapassorn and Boodde, Orawan and Chumsing, Wilairat and Jirawattanapong, Pichai and Sukmak, Manakorn and Woonwong, Yonlayong and Thanantong, Narut and Wajjwalku, Worawidh and Boonsoongnern, Alongkot},
title = {Comparative Humoral Immune Responses Induced by Live-Attenuated and Inactivated Porcine Epidemic Diarrhea Vaccines in Replacement Gilts},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {3},
pages = {231},
doi = {10.3390/vaccines14030231}
}
EUVIMED